Proximate Analysis of Moringa oleifera Leaves and the Antimicrobial Activities of Successive Leaf Ethanolic and Aqueous Extracts Compared with Green Chemically Synthesized Ag-NPs and Crude Aqueous Extract against Some Pathogens.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Moringa oleifera*/chemistry ; Anti-Infective Agents*/analysis; Humans ; Animals ; Escherichia coli ; Ethanol/analysis ; Water/analysis ; Plant Leaves/chemistry ; Plant Extracts/chemistry

Research on the use of different parts of the Moringa oleifera plant as a nutritional and pharmaceutical resource for human and animals has increased in recent years. This study aimed to investigate the chemical composition and the TPCs and TFCs of Moringa leaves, the antimicrobial activities of Moringa successive ethanolic, aqueous, crude aqueous extracts, and green-chemically synthesized characterized Ag-NPs. The results indicated that the ethanolic extract recorded the highest activity against E. coli . On the other side, the aqueous extract showed higher activity, and its effects ranged from 0.03 to 0.33 mg/mL against different strains. The MIC values of Moringa Ag-NPs against different pathogenic bacteria ranged from 0.05 mg/mL to 0.13 mg/mL, and the activity of the crude aqueous extract ranged from 0.15 to 0.83 mg/mL. For the antifungal activity, the ethanolic extract recorded the highest activity at 0.04 mg/mL, and the lowest activity was recorded at 0.42 mg/mL. However, the aqueous extract showed effects ranging from 0.42 to 1.17 mg/mL. Moringa Ag-NPs showed higher activity against the different fungal strains than the crude aqueous extract, and they ranged from 0.25 to 0.83 mg/mL. The MIC values of the Moringa crude aqueous extract ranged from 0.74 to 3.33 mg/mL. Moringa Ag-NPs and their crude aqueous extract may be utilized to boost antimicrobial attributes.

Lett Appl Microbiol. 2011 Aug;53(2):186-92. (PMID: 21605145)
BMC Complement Altern Med. 2016 Jan 11;16:9. (PMID: 26753836)
Food Chem Toxicol. 2015 Sep;83:1-9. (PMID: 26032632)
Mycoses. 1995 May-Jun;38(5-6):191-5. (PMID: 8531930)
Appl Biochem Biotechnol. 2010 Sep;162(1):127-33. (PMID: 19685213)
Phytother Res. 2019 Nov;33(11):2870-2903. (PMID: 31453658)
Heliyon. 2019 Mar 27;5(3):e01404. (PMID: 30976685)
Phytother Res. 2007 Jan;21(1):17-25. (PMID: 17089328)
Pharmacogn Mag. 2018 Apr-Jun;14(54):191-194. (PMID: 29720830)
J Ethnopharmacol. 2007 Sep 5;113(2):284-91. (PMID: 17686593)
Molecules. 2020 Aug 15;25(16):. (PMID: 32824133)
Evid Based Complement Alternat Med. 2009 Dec;6(4):489-94. (PMID: 18955252)
Nat Protoc. 2008;3(2):163-75. (PMID: 18274517)
Folia Microbiol (Praha). 2010 Sep;55(5):422-6. (PMID: 20941575)
Biotechnol Rep (Amst). 2020 Jan 31;25:e00427. (PMID: 32055457)
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S71-S85. (PMID: 30043665)
Am J Clin Pathol. 1966 Apr;45(4):493-6. (PMID: 5325707)
Polymers (Basel). 2022 Feb 15;14(4):. (PMID: 35215655)
Asian Pac J Trop Biomed. 2011 Dec;1(6):439-42. (PMID: 23569809)
Asian Pac J Trop Med. 2011 Mar;4(3):201-4. (PMID: 21771453)
Mymensingh Med J. 2022 Oct;31(4):976-982. (PMID: 36189541)
Med Vet Entomol. 2004 Jun;18(2):205-7. (PMID: 15189247)
J Pharm Bioallied Sci. 2018 Oct-Dec;10(4):181-191. (PMID: 30568375)
Molecules. 2020 Feb 22;25(4):. (PMID: 32098328)
Food Nutr Bull. 2018 Mar;39(1):149-170. (PMID: 29284305)
PLoS One. 2014 Oct 27;9(10):e111427. (PMID: 25347074)
Early Hum Dev. 2018 Aug;123:37-38. (PMID: 29685578)
Front Pharmacol. 2018 Feb 16;9:108. (PMID: 29503616)
Front Pharmacol. 2020 Jan 09;10:1480. (PMID: 31998121)
Meat Sci. 2012 Aug;91(4):441-7. (PMID: 22465510)
Int J Antimicrob Agents. 2004 Sep;24(3):226-33. (PMID: 15325425)
Chemosphere. 2009 Nov;77(7):934-8. (PMID: 19747711)
Int J Antimicrob Agents. 2005 Nov;26(5):343-56. (PMID: 16323269)
Rev Panam Salud Publica. 2011 Dec;30(6):555-60. (PMID: 22358402)
J Nat Prod. 1994 Sep;57(9):1256-61. (PMID: 7798960)
PLoS One. 2019 Aug 12;14(8):e0220950. (PMID: 31404086)
J Appl Microbiol. 2015 Sep;119(3):666-76. (PMID: 26109449)
Int J Mol Sci. 2015 Jun 05;16(6):12791-835. (PMID: 26057747)

GINOP-2.3.2-15-2016-00054 Hungarian Government and the European Union; Széchenyi 2020 Programme Hungarian Government and the European Union with the co-funding of the European Regional Development Fund

Keywords: Ag-NPs; Moringa oleifera; chemical composition; pathogenic bacteria; plant infecting fungi

0 (Anti-Infective Agents)
3K9958V90M (Ethanol)
059QF0KO0R (Water)
0 (Plant Extracts)

Date Created: 20230225 Date Completed: 20230228 Latest Revision: 20230228

20230228

PMC9960608

10.3390/ijms24043529

36834941